Breast cancer (triple negative breast cancer (TNBC))
Clinical trials for Breast cancer (triple negative breast cancer (TNBC)) explained in plain language.
Never miss a new study
Get alerted when new Breast cancer (triple negative breast cancer (TNBC)) trials appear
Sign up with your email to follow new studies for Breast cancer (triple negative breast cancer (TNBC)), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can immunotherapy plus chemo wipe out Triple-Negative breast cancer before surgery?
Disease control CompletedResearchers are testing whether adding the immunotherapy drug tislelizumab to standard TAC chemotherapy helps shrink triple-negative breast cancer before surgery. The trial enrolls 36 women with newly diagnosed triple-negative breast cancer. Participants receive six cycles of tis…
Matched conditions: BREAST CANCER (TRIPLE NEGATIVE BREAST CANCER (TNBC))
Phase 2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Custom RNA vaccines take on aggressive breast cancer in first human test
Disease control CompletedThis first-in-human trial tested personalized RNA vaccines designed to target each patient's unique tumor mutations in triple negative breast cancer (TNBC). 42 participants received two custom-made vaccines to stimulate their immune system. The main goal was to check safety and t…
Matched conditions: BREAST CANCER (TRIPLE NEGATIVE BREAST CANCER (TNBC))
Phase 1 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC